The CDC Public Health Cancer Genomics Program: Translating Research into Public Health Practice

 

The purpose of this cooperative agreement is to develop effective approaches for translation of evidence-based recommendations and implementation of activities in cancer genomics in public health settings. Specifically applicants will be asked to translate the USPSTF recommendation on screening for Hereditary Breast and Ovarian Cancer Syndrome and the EGAPP recommendation on tumor screening for Lynch syndrome for implementation into public health practice.

General information about this opportunity
Last Known Status
Active
Program Number
93.380
Federal Agency/Office
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Fiscal Year 2019 NA
Authorization
This program is authorized under the following sections: Section 317(k)(2) of the Public Health Service Act (PHS Act), 42 U.S.C. 247b (k)(2); Section 301(a) of the PHS Act, 42 U.S.C. 241(a)., Title Public Health Service Act, Section 317(k)(2))
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Non-profit organizations, state health department or tribal organization, universities
Beneficiary Eligibility
Non-profit organizations, state health department or tribal organization, universities
Credentials/Documentation
Not applicable.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable.
Application Procedure
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applications will consist of submitting a work plan and program narrative that details program goals and outcomes, and, must include a detailed work plan with their planned activities for year 1. In addition, a detailed budget and justification narrative will be required, as well as a detailed staffing plan.
Award Procedure
All applications that are complete and responsive to this competitive Notice of Funding Opportunity announcement will be evaluated for programmatic and technical merit. Applications will be reviewed for completeness by the Office of Financial Resources (OFR) staff and for responsiveness jointly by the National Center for Chronic Disease Prevention and Health Promotion and the Office of
Deadlines
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 120 to 180 days.
Appeals
Not applicable.
Renewals
From 120 to 180 days. 5 year with 12-month budget periods. Renewals are based on availability of funds.
How are proposals selected?
Not applicable.
How may assistance be used?
Staffing, program activities, data acquisition, program-related travel
What are the requirements after being awarded this opportunity?
Reporting
Not applicable.
Auditing
Not applicable.
Records
Not applicable.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Five year funding opportunity (FY19, FY20, FY21, FY22, FY23).
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Juan Rodriguez
4770 Buford Hwy NE
Mailstop F76
Atlanta, GA 30341 USA
fph4@cdc.gov
Phone: 770-488-3086
Financial Information
Account Identification
75-0943-0-1-551
Obligations
(Cooperative Agreements) FY 18$0.00; FY 19 est $2,100,516.00; FY 20 est $2,100,516.00; FY 17 - This number supports a new FY19 NOFO. Period of Performance will begin 9/29/19.
Range and Average of Financial Assistance
5-programs are currently funded in FY18, at about $350,000 each. They were funded at a similar amount in FY17.
Regulations, Guidelines and Literature
Not applicable.

 



Federal Grants Resources